Trial Profile

A Randomized, double-blind, placebo-controlled, USA clinical study of inhaled nitric oxide (NO) using LungFit® PRO

Status: Planning

Phase of Trial: Phase III

Latest Information Update: 24 Feb 2024

Price :

$35 ^*

Note:

Adis is an information provider.
Final gross price and currency may vary according to local VAT and billing address.
Your purchase entitles you to full access to the information contained in our trial profile at the time of purchase.
A link to download a PDF version of the trial profile will be included in your email receipt.

At a glance

Drugs Nitric oxide (Primary)
Indications Bronchiolitis; Community-acquired pneumonia; COVID 2019 infections; Pneumonia
Focus Registrational; Therapeutic Use
Sponsors Beyond Air

Most Recent Events

12 Feb 2024 According to a Beyond Air media release, this study plan to include 50 patients at up to 10 sites. Top line data expected mid-year 2025 from VCAP study as trial is expected to extend over two seasons.
03 Oct 2022 According to a Beyond Air media release, the company expect to initiate this trial in the fourth quarter of 2023, pending discussions with the FDA.
18 Aug 2021 New trial record

You need to be a logged in or subscribed to view this content Request demo (opens in a new window)

If your organization or you do not have a subscription, try one of the following:

Contacting your organization’s admin about adding this content to your AdisInsight subscription
Buying a PDF version of any individual profile
Request a free trial (opens in a new window)

If your organization has a subscription, there are several access options, even while working remotely:

Working within your organization’s network
Login with username/password or try to access via your institution
Persisted access using your organization’s identifier stored in your user browser for 90 days

For assistance, contact us at asktheexpert.adisinsight@springer.com